1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Latvia Pharmaceuticals and Healthcare Report Q3 2016

Latvia Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 75 pages

Includes 3 FREE quarterly updates

BMI View: Latvia's pharmaceutical and healthcare markets will be shaped by the country's ongoing fiscalausterity measures. Already severely underfunded, the healthcare sector is facing additional cuts which areproving highly unpopular with the public. The generic medicines sector will drive modest growth within thepharmaceutical market given an increasing reliance on lower-value drugs due to budgetary containmentmeasures.

Headline Expenditure Projections

- Pharmaceuticals: EUR338mn (USD372mn) in 2015 to EUR353mn (USD377mn) in 2016; +4.4% inlocal currency terms and -1.5% in US dollar terms. Forecast downgraded from previous quarter.

- Healthcare: EUR1.01n (USD1.11bn) in 2015 to EUR1.05bn (USD1.12bn) in 2015; +4.0% in localcurrency terms and 1.4% in US dollar terms. Forecast downgraded from previous quarter.

Table Of Contents

Latvia Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Latvia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Latvia 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2012-2020) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 21
OTC Medicine Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Latvia 2012-2020) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Latvia 2014-2020) 25
Table: Pharmaceutical Trade Data And Forecasts local currency (Latvia 2014-2020) 26
Pharmaceuticals and Healthcare Risk/Reward Index 27
Central And Eastern Europe Risk/Reward Index - Q3 2016 27
Latvia Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Intellectual Property Issues 37
Pricing Regime 37
Reimbursement Regime 39
Market Overview 41
Healthcare Sector 42
Table: Healthcare Resources (Latvia 2010-2015) 44
Table: Healthcare Personnel (Latvia 2010-2015) 45
Table: Healthcare Activity (Latvia 2010-2015) 45
Research and Development 45
Biotechnology 46
Clinical Trials 48
Epidemiology 49
Competitive Landscape 52
Research-Based Industry 52
Table: Multinational Market Activity 53
Generic Drugmakers 54
Pharmaceutical Distribution 54
Pharmaceutical Retail Sector 55
Company Profile 57
Grindeks 57
Olainfarm 61
Demographic Forecast 64
Table: Population Headline Indicators (Latvia 1990-2025) 65
Table: Key Population Ratios (Latvia 1990-2025) 65
Table: Urban/Rural Population and Life Expectancy (Latvia 1990-2025) 66
Table: Population By Age Group (Latvia 1990-2025) 66
Table: Population By Age Group % (Latvia 1990-2025) 67
Glossary 69
Methodology 71
Pharmaceutical Expenditure Forecast Model 71
Healthcare Expenditure Forecast Model 71
Notes On Methodology 72
Risk/Reward Index Methodology 73
Index Overview 74
Table: Pharmaceutical Risk/Reward Index Indicators 74
Indicator Weightings 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.